A study has indicated that patients with advanced inoperable stage 3 lung cancer can benefit from an improved rate of survival when undergoing concurrent chemotherapy and proton therapy.
Browsing: Taxonomy > Chemotherapy
A novel global study has set a risk-based standard in order to personalize chemotherapy for colon cancer following surgery.
This article provides a immunotherapy perspective of Ipilimumab, a CTLA-4-targeted monoclonal antibody, reviewing drug mechanism, blockade, combination therapies and future prospectives.
This article outlines the importance of homologous recombination repair pathway in development of breast carcinoma (BC), and the influence of gene alterations in chemotherapy treated BC samples.
Discover the highlights of the 26th World Congress of International Association of Surgeons Gastroenterologists and Oncologists in Seoul discussing the epidemiology and treatment of gallbladder tumors.
In this case report the authors present systematic therapy as a multimodality tool in the management of patients with oligometastatic disease.
Researchers have demonstrated the feasibility of utilizing tumor sequencing when guiding chemotherapy in early-breast cancer patients.
In this systematic review from Pharmacogenomics find out about the influence pharmacogenetics and ethnicity can have on oxaliplatin therapy for colorectal cancer.
Researchers have developed a calculator that reasonably predicts which esophageal adenocarcinoma patients may gain overall survival benefit from neoadjuvant chemoradiation.
How have transarterial therapies for hepatocellular carcinoma evolved over recent years? What impact have these changes had on patient outcomes? Read more in our partner journal Hepatic Oncology.